MIHARI project, a preceding study of MID-NET, adverse event detection database of Ministry Health of Japan-Validation study of the signal detection of adverse events of drugs using export data from EMR and medical claim data.
We studied the effectiveness of the direct data collection from electronic medical records (EMR) when it is used for monitoring adverse drug events and also detection of already known adverse events. In this study, medical claim data and SS-MIX2 standardized storage data were used to identify four d...
Guardado en:
Autores principales: | Hiroshi Watanabe, Kiyoteru Takenouchi, Michio Kimura |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8d2e6be4694942dcb60b5a1ed61be1d6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Drug-use patterns and severe adverse events with disease-modifying drugs in patients with multiple sclerosis: a cohort study based on German claims data
por: Simbrich A, et al.
Publicado: (2019) -
Adverse Events Related to Off-Label Drugs Using Spontaneous Adverse Event Reporting Systems
por: Han N, et al.
Publicado: (2021) -
A pharmacovigilance study of association between proton pump inhibitor and dementia event based on FDA adverse event reporting system data
por: Bin Wu, et al.
Publicado: (2021) -
Pulmonary adverse drug event data in hypertension with implications on COVID-19 morbidity
por: Majid Jaberi-Douraki, et al.
Publicado: (2021) -
Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe.
por: Emanuel Raschi, et al.
Publicado: (2013)